Effects of Treatment of Sleep Apnea on Metabolic Syndrome

PHASE2CompletedINTERVENTIONAL
Enrollment

50

Participants

Timeline

Start Date

January 31, 2004

Primary Completion Date

September 30, 2008

Study Completion Date

September 30, 2008

Conditions
Impaired Glucose ToleranceObstructive Sleep Apnea
Interventions
DEVICE

Continuous Positive Airway Pressure (CPAP) (Philips-Respironics RemStar Pro® CPAP)

Subjects will be randomized to 8 weeks of CPAP or sham-CPAP, followed by the alternate therapy after a one month wash-out.

DEVICE

Sham-Continuous Positive Airway Pressure (CPAP) (Philips-Respironics)

Subjects will be randomized to 8 weeks of CPAP or sham-CPAP, followed by the alternate therapy after a one month wash-out.

All Listed Sponsors
collaborator

National Institutes of Health (NIH)

NIH

collaborator

National Center for Research Resources (NCRR)

NIH

collaborator

Beth Israel Deaconess Medical Center

OTHER

collaborator

Case Western Reserve University

OTHER

lead

Brigham and Women's Hospital

OTHER

NCT01385995 - Effects of Treatment of Sleep Apnea on Metabolic Syndrome | Biotech Hunter | Biotech Hunter